Related Experiment Video
Updated: May 13, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Retinoic acid-induced HOXA5 expression is co-regulated by HuR and miR-130a
1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China.
Abstract:
Retinoic acid (RA) has been used as a chemopreventive agent for breast cancer. It has been shown that HOXA5 is a critical mediator of RA-induced cell growth inhibition. However, the molecular mechanisms underlying RA-induced HOXA5 expression remain largely unknown. Here we report that in addition to transcriptional regulation, post-transcriptional regulation also contributes to RA-induced HOXA5 expression. miR-130a, a c-Myc responsive miRNA, represses HOXA5 cellular levels under unstressed condition. Upon RA treatment, c-Myc is quickly degraded via the proteasome-dependent pathway. This in turn decreases miR-130a levels and de-represses the translation of HOXA5. We also show that the de-repression of HOXA5 translation is dependent on the RNA-binding protein Human antigen R (HuR), which binds to 3'UTR of HOXA5 mRNA and increases its stability in response to RA treatment. Collectively, these results demonstrate that HuR and miR-130a dynamically regulate HOXA5 gene expression via modulating HOXA5 mRNA turnover and translation, respectively, thereby contributing to RA-induced growth inhibition.
Insights
Retinoic acid (RA) uses post-transcriptional regulation to control HOXA5 expression in breast cancer. This involves miR-130a and HuR protein, impacting cell growth inhibition.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Retinoic acid (RA) is a chemopreventive agent for breast cancer.
- HOXA5 is a critical mediator of RA-induced breast cancer cell growth inhibition.
- The molecular mechanisms of RA-induced HOXA5 expression are not fully understood.
Purpose of the Study:
- To elucidate the post-transcriptional regulatory mechanisms of RA-induced HOXA5 expression.
- To investigate the roles of miR-130a and Human antigen R (HuR) in HOXA5 regulation.
Main Methods:
- Investigated RA treatment effects on c-Myc, miR-130a, and HOXA5 levels.
- Utilized proteasome inhibition to study c-Myc degradation.
- Examined HuR binding to HOXA5 mRNA 3'UTR and its effect on mRNA stability.
Main Results:
- RA treatment leads to rapid, proteasome-dependent degradation of c-Myc.
- Decreased c-Myc levels result in reduced miR-130a, de-repressing HOXA5 translation.
- HuR binds to HOXA5 mRNA 3'UTR, enhancing its stability and translation in response to RA.
Conclusions:
- HOXA5 expression is regulated by both transcriptional and post-transcriptional mechanisms.
- HuR and miR-130a dynamically control HOXA5 mRNA turnover and translation.
- These regulatory pathways contribute to retinoic acid's breast cancer chemoprevention effects.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Co-activators and Co-repressors
Co-activators and Co-repressors
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
